Why is Medplus Health Services Ltd falling/rising?

Strong Price Performance Against Benchmarks

Medplus Health’s recent price movement has outpaced the broader market and its sector peers. Over the past week, the stock has gained 11.20%, substantially higher than the Sensex’s 2.30% rise. Similarly, the one-month return of 5.21% contrasts with the Sensex’s decline of 2.36%. Year-to-date, the stock has appreciated by 6.80%, while the Sensex has fallen by 1.74%. Even on a one-year horizon, Medplus Health has delivered a 13.36% return, outperforming the Sensex’s 8.49% gain. These figures underscore the stock’s resilience and appeal amid broader market volatility.

Positive Momentum in Trading and Sector Dynamics

On 03-Feb, Medplus Health outperformed the retailing sector by 2.09%, with the sector itself gaining 2.75%. The stock reached an intraday high of ₹865, marking a 5.34% increase during the session. Notably, the stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling sustained bullish momentum. Investor interest has surged, as evidenced by a 72.56% rise in delivery volume to 83,060 shares on 02-Feb compared to the five-day average. This heightened participation reflects growing confidence among market participants, further supporting the price rally.

Robust Financial Metrics Underpinning the Rise

Medplus Health’s upward trajectory is supported by a string of positive quarterly results, with six consecutive quarters of growth. The company’s half-year return on capital employed (ROCE) stands at a healthy 11.47%, indicating efficient utilisation of capital. Its inventory turnover ratio of 4.91 times reflects strong operational efficiency, while quarterly net sales have reached a peak of ₹1,806.12 crore, signalling robust revenue growth.

Valuation metrics also favour the stock. With a ROCE of 11.3 and an enterprise value to capital employed ratio of 4.3, Medplus Health is attractively valued relative to its peers. The stock trades at a discount compared to the average historical valuations of comparable companies, making it an appealing option for investors seeking value. Over the past year, profits have surged by 56.4%, outpacing the stock’s 13.36% return, resulting in a price-to-earnings-growth (PEG) ratio of 0.9, which suggests the stock is undervalued relative to its earnings growth potential.

Liquidity and Trading Conditions

The stock’s liquidity remains adequate for active trading, with the current trading volume supporting a trade size of approximately ₹0.17 crore based on 2% of the five-day average traded value. This level of liquidity ensures that investors can enter and exit positions without significant price impact, further enhancing the stock’s attractiveness.

Conclusion: Why Medplus Health Is Rising

The rise in Medplus Health Services Ltd’s share price on 03-Feb is a reflection of its strong financial performance, attractive valuation, and positive market sentiment. The company’s consistent quarterly growth, efficient capital utilisation, and expanding sales have bolstered investor confidence. Coupled with favourable sector trends and increased trading volumes, these factors have propelled the stock well above key technical levels and benchmark indices. While the stock has outperformed the Sensex and its sector peers, investors should continue to monitor valuation metrics and market conditions to assess ongoing opportunities.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →